Delivery Order SPE2DB22D2009-SPE2DB25FM0SE
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,231.35 for WIXELA 250-50 INHUB 60S, a pharmaceutical product, with a completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child task order under AmerisourceBergen Drug Corp's larger contract vehicle with the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,349.80 to AmerisourceBergen Drug Corp for WIXELA 500-50 INHUB 60S, a pharmaceutical product, with an ultimate completion date of August 1, 2025. This firm fixed-price, non-set-aside delivery order was awarded on July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- This delivery order, valued at $1,373.64, was awarded to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Wixela 500-50 Inhub 60s pharmaceutical product. The contract, issued by the Defense Logistics Agency (DLA), carries a firm fixed price structure with no set-aside designation and is scheduled for completion by August 1, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Wixela 500-50 inhub 60s, a pharmaceutical product, on August 5, 2025, with a ceiling value of $3,241.44. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, represents performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The contract is a child order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,483.86 to AmerisourceBergen Drug Corp for WIXELA 100-50 inhalation powder, a combination asthma and COPD medication. Issued on August 5, 2025, with an ultimate completion date of August 6, 2025, this firm fixed-price delivery order was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply the WIXELA 250-50 INHUB 60S medication. The $1,470.90 Firm Fixed Price contract has a performance period extending to May 12, 2025. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which enables the company to provide a wide range of pharmaceutical products...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,349.05 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of WIXELA 100-50 INHB 60S pharmaceuticals. The contract has a completion date of February 29, 2024 and was awarded on February 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $1,610.92, is for the supply of the pharmaceutical product WIXELA 250-50 INHUB 60S. This delivery order is a part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,060.22 firm fixed-price delivery order is for the supply of WIXELA 250-50 INHUB 60S, a medical product, with a performance period ending on April 30, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide WIXELA 250-50 INHUB 60S pharmaceutical products. The $1,991.37 order has a completion date of January 9, 2024. Amerisourcebergen Drug Corp is a large, for-profit pharmaceutical sourcing and distribution company that serves as a prime contractor to DLA Troop Support Medical, supplying a range of pharmaceutical and medical...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0SEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,948.02 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and was fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply deliveries to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company's delivery orders under the SPE2DX IDC encompass a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for WIXELA—a combination inhaled medication—reflects the company's continued role in supplying medications to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DLA Troop Support is planning to expand pharmaceutical vendor capacity through its Generation V program, which will establish regional contracts with multiple awards, indicating the strategic importance of maintaining diverse supplier relationships for military and veteran healthcare support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 8/5/25 |